Sustained reduction of attentional bias to smoking cues by smartphone-delivered attentional bias modification training for smokers

• Published in: Psychology of addictive behaviors
• Main Authors: Robinson, Jason D, Cui, Yong, Linares Abrego, Paulina, Engelmann, Jeffrey M, Prokhorov, Alexander V, Vidrine, Damon J, Shete, Sanjay, Cinciripini, Paul M
• Format: Journal Article
• Language: English
• Published: United States 01.11.2022
• ISSN: 1939-1501
• DOI: 10.1037/adb0000805

Cigarette smoking is thought to be at least partially maintained by the attentional bias (AB) toward smoking cues that develops as a consequence of drug dependence. This study evaluated the impact of smartphone-delivered, in-home attentional bias modification (ABM) to reduce AB to smoking cues and to reduce smoking behavior and withdrawal-related symptoms when used as an adjunct to conventional smoking cessation treatment. Participants ( = 246) were treatment-seeking smokers who completed up to 13 days of either ABM designed to train attention away from smoking cues, using a modified dot-probe task, or sham training, followed by 8 weeks of nicotine replacement therapy and counseling. Outcomes measured at baseline, 1-day post-ABM training, and 8 weeks post-ABM training included AB to smoking images and words using the dot-probe and smoking Stroop tasks, respectively, along with cigarettes per day, craving, and smoking abstinence. We found that ABM training reduced AB to smoking stimuli on both the dot-probe task, η ² = 0.056, 90% CI [0.024, 0.097], and the smoking Stroop task, η ² = 0.017, 90% CI [0.002, 0.044], up to 8 weeks after ABM training when covarying for baseline response, but did not concurrently decrease smoking behavior or craving. Thirteen days of smartphone-delivered ABM training, as an adjunct to smoking cessation treatment, reduced AB to both modality-specific and cross-modality smoking cues but did not impact smoking-related behavior. While ABM can reduce AB to smoking cues across modalities, it is unclear whether it has therapeutic potential as an adjunct to conventional smoking cessation therapy. (PsycInfo Database Record (c) 2022 APA, all rights reserved).